Mahamaya Lifesciences Ltd.
Fundamentals
- Market cap
- ₹390 cr
- P/E
- 30.20×
- ROE
- 26.19%
- Debt / equity
- 1.18
- 52-week range
- 111.00 — 205.05
The timeline — 2 notes on Mahamaya Lifesciences Ltd.
May 2026
- 25 May 26 · 1:57 PM IST Brief Brief · Earnings
Mahamaya Lifesciences confirms FY26 results with no surprises
The company filed its audited standalone and consolidated results for the year ended March 31, 2026, confirming previously disclosed figures.
- 25 May 26 · 1:41 PM IST Brief Brief · Earnings
Mahamaya Lifesciences posts ₹16.72 cr profit in first annual report
The agrochemical firm grew annual revenue by 24.5% to ₹328.87 crore, while over half of its IPO proceeds remain parked in fixed deposits.